Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{202635,
        author = {Saniya Yasin Momin and Resham Raju Sayyed and Riza Ashfaq Momin and Dr.Kranti Ajit Dale},
        title = {A REVIEW ON “PLANT BASED HERBAL MEDICINES AND THEIR PHARMACOLOGICAL ACTION FOR ASTHMA”},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {12},
        pages = {8217-8225},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=202635},
        abstract = {Asthma is a chronic inflammatory disorder of the airways characterized by reversible airflow obstruction, bronchial hyperresponsiveness, mucus hypersecretion, wheezing, cough, and breathlessness. The reviewed studies collectively explore the role of herbal and Ayurvedic interventions as complementary approaches to conventional asthma therapy, which often relies on bronchodilators and corticosteroids but may produce long-term adverse effects. Clinical evaluation of Boswellia carterii demonstrated that its extract containing 37.5% boswellic acids improved pulmonary function (FEV1, PEFR), reduced asthma attack frequency—particularly in severe persistent cases—and showed good tolerability. Boswellic acids act by inhibiting 5-lipoxygenase and leukotriene synthesis, thereby reducing airway inflammation. An Ayurvedic comparative clinical study on Kantakari Ghrita and Vasa Ghrita for Tamaka Shwasa (bronchial asthma) reported significant symptomatic and objective improvements, with 76.79% overall improvement in the Kantakari group compared to 37.94% in the Vasa group. These formulations, administered through Snehapana followed by Virechana, aim to correct Kapha-Vata imbalance and clear airway obstruction. Studies on Shati (Simhayadi Kwath with Shati Churna) showed reductions in eosinophil count, ESR, and serum IgE, indicating anti-inflammatory and immunomodulatory effects. Euphorbia hirta and” Lobelia inflata” are traditionally recognized for bronchodilatory, expectorant, and antispasmodic properties. Overall, the combined findings suggest that these herbal therapies possess anti-inflammatory, bronchodilatory, and immunomodulatory actions that may complement standard asthma treatment. However, larger, long-term randomized controlled trials are required to establish standardized dosing, long-term safety, and definitive clinical efficacy},
        keywords = {Boswellia carterii, bronchodilatory, Kantakari Ghrita, bronchial asthma, Asthma; Herbal therapy; Ayurveda, Shati, Euphorbia, Jatamansi, Lobelia; Bronchodilator, Anti-inflammatory, Immunomodulatory Phytoconstituents.},
        month = {May},
        }